BCL2 and cancer: Till date, cell cycle arrest and apoptosis have been reported as the primary mode of action of Artemisinin and its derivatives in cancer cells with Bax, Bcl2, caspase 3, cyclinB1, Cdc2 and Mdm2 as its popularly recognized targets (67, 68).